Decision Considerations – Aerospace Medical Dispositions
Item 41. G-U System – Neoplastic Disorders
| Disease/Condition | Evaluation Data | Disposition |
|---|---|---|
| A. Benign Prostatic Hypertrophy (BPH) or elevated PSA | If the airman has findings consistent with uncomplicated BPH with no evidence of prostate cancer: | ISSUE Summarize this history in Block 60 |
Notes: See Pharmaceuticals section for list of medications usually allowed.
| Disease/Condition | Evaluation Data | Disposition |
|---|---|---|
| A. Prostate Cancer Non metastatic with treatment completed 5 or more years ago |
If NO recurrence or ongoing treatment: | ISSUE Summarize this history in Block 60. |
| B. Prostate Cancer Non metastatic with treatment completed less than 5 years ago |
Follow CACI worksheet. | Follow the CACI – Prostate Cancer Worksheet (PDF). Note in Block 60. |
| C. Prostate Cancer with Metastatic disease current OR any time in the past OR Recurrence of disease including a biochemical recurrence (BCR) after prostatectomy |
Submit the following to the FAA review: ☐ Current status report from oncologist describing treatment plan, how long the condition has been stable, and prognosis; ☐ List of medications and presence or absence of side effects with specific attention to any chemotherapy, steroids, or hormone agents and dates used; ☐ Treatment records including clinic notes or a summary letter describing initial staging, disease course, locations of metastatic disease, and stability; ☐ Operative notes and discharge summary, if applicable; ☐ Pathology report(s), if applicable; and ☐ Results of MRI/CT or PET scan reports. (In some cases, the actual CDs will be required in DICOM format for FAA review). |
DEFER Initial Special Issuance – Requires FAA Decision Follow up Special Issuance will be per the airman's authorization letter |
Notes: If the airman is currently on radiation or chemotherapy, the treatment course should be completed before medical certification can be considered.